comparemela.com
Home
Live Updates
Akthelia Pharma - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Akthelia pharma - Page 1 : comparemela.com
Antibiotic Resistance Markets Therapeutics, by Pathogen and
Dublin, May 27, 2024 (GLOBE NEWSWIRE) The
Theravance biopharma
Procarta biosystems
Ampliphi biosciences
Eligo bioscience
Johnson janssen
Bioversys gmb
Biofilm pharma
Akthelia pharma
Absynth biologics
Xellia pharmaceutials
Redhill biopharma
Pherecydes pharma
Deinobiotics deinove
Qpex biopharma
Aridis pharmaceuticals inc
Contrafect corporation
Global Antibiotic Resistance Market Research Report 2023-2027: Search for Alternatives to Antibiotics Creates New Goldrush
/PRNewswire/ The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &.
United states
Akthelia pharma
Xellia pharmaceutials
Qpex biopharma
Redhill biopharma
Biofilm pharma
Theravance biopharma
Procarta biosystems
Absynth biologics
Eligo bioscience
Laura wood
Pherecydes pharma
Johnson janssen
Bioversys gmb
Deinobiotics deinove
Ampliphi biosciences
Global Antibiotic Resistance Markets, 2023-2027: Beyond
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) The
United states
Qpex biopharma
Xellia pharmaceutials
Procarta biosystems
Biofilm pharma
Johnson janssen
Theravance biopharma
Absynth biologics
Bioversys gmb
Deinobiotics deinove
Eligo bioscience
Redhill biopharma
Akthelia pharma
Pherecydes pharma
Ampliphi biosciences
Co ltd
Icelandic deep tech startup and the University of Iceland secure a €6M EU Horizon grant to combat antimicrobial resistance (AMR)
Reykjavik-based biopharma startup Akthelia Pharmaceuticals and the University of Iceland have been awarded a €6 million EU Horizon Grant to fund the IN-ARMOR
Egill masson
Gudmundur gudmundsson
Akthelia pharma
University of iceland
Akthelia pharmaceuticals
Professor gudmundur gudmundsson
Cell biology
Akthelia, University of Iceland receive funds for IN-ARMOR project
Akthelia Pharmaceuticals, along with the University of Iceland, has received a €6m EU Horizon Grant for the IN-ARMOR project.
Egill masson
Gerd altmann
Akthelia pharma
Akthelia pharmaceuticals
European union eu horizon grant
World health organisation
University of iceland
European union
Horizon grant
vimarsana © 2020. All Rights Reserved.